Attached files
| file | filename |
|---|---|
| EX-4.4 - DESCRIPTION OF AVANOS MEDICAL, INC. SECURITIES - Avanos Medical, Inc. | avns2020form10kex44.htm |
| EX-32.B - SECTION 906 CFO CERTIFICATION - Avanos Medical, Inc. | avns2020form10kex32b.htm |
| EX-32.A - SECTION 906 CEO CERTIFICATION - Avanos Medical, Inc. | avns2020form10kex32a.htm |
| EX-31.B - SECTION 302 CFO CERTIFICATION - Avanos Medical, Inc. | avns2020form10kex31b.htm |
| EX-31.A - SECTION 302 CEO CERTIFICATION - Avanos Medical, Inc. | avns2020form10kex31a.htm |
| EX-24 - POWERS OF ATTORNEY - Avanos Medical, Inc. | avns2020form10kex24.htm |
| EX-21 - SUBSIDIARIES OF THE CORPORATION - Avanos Medical, Inc. | avns2020form10kex21.htm |
| EX-10.8 - FORM OF AWARD AGREEMENT - Avanos Medical, Inc. | avns2020form10kex108.htm |
| 10-K - FORM 10-K - Avanos Medical, Inc. | avns-20201231.htm |
Exhibit No. 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-199748 and 333-233071 on Form S-8 of our reports dated February 19, 2021, relating to the consolidated financial statements of Avanos Medical, Inc. and subsidiaries (the “Company”), and the effectiveness of the Company’s internal control over financial reporting, appearing in this Annual Report on Form 10-K of Avanos Medical, Inc. for the year ended December 31, 2020.
/s/ DELOITTE & TOUCHE LLP | ||
| Deloitte & Touche LLP | ||
| Atlanta, Georgia | ||
| February 19, 2021 | ||